Overview
Genetic syndromes with corpus callosum agenesis or dysgenesis as a major feature represent a broad category of rare genetic conditions in which the corpus callosum — the large bundle of nerve fibers connecting the left and right hemispheres of the brain — fails to develop normally (agenesis) or develops incompletely (dysgenesis). This grouping, classified under Orphanet code 269573, encompasses numerous distinct genetic syndromes where this brain malformation is a defining or prominent clinical characteristic rather than an incidental finding. The corpus callosum plays a critical role in interhemispheric communication, and its absence or malformation can lead to a wide range of neurological and developmental consequences. Clinical features vary considerably depending on the specific underlying syndrome but commonly include intellectual disability of variable severity, developmental delay, seizures or epilepsy, motor coordination difficulties, and speech and language impairments. Many of these syndromes also involve additional organ systems, with associated features potentially including craniofacial anomalies, skeletal malformations, cardiac defects, ocular abnormalities, and growth disturbances. Some well-known syndromes within this category include Aicardi syndrome, Mowat-Wilson syndrome, Acrocallosal syndrome, and Andermann syndrome, among many others. Each has its own distinct genetic basis, inheritance pattern, and constellation of associated features. There is currently no cure or specific treatment that can restore normal corpus callosum development. Management is supportive and multidisciplinary, tailored to the specific syndrome and the individual patient's needs. This may include antiepileptic medications for seizure control, physical and occupational therapy for motor difficulties, speech-language therapy, special education services, and surgical interventions for associated structural anomalies. Early intervention programs and regular developmental monitoring are important components of care. Genetic counseling is recommended for affected families to clarify the specific diagnosis, inheritance pattern, and recurrence risk.
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.
Community
No community posts yet. Be the first to share your experience with Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.
Start the conversation →Latest news about Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature
No recent news articles for Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature
What is Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature?
Genetic syndromes with corpus callosum agenesis or dysgenesis as a major feature represent a broad category of rare genetic conditions in which the corpus callosum — the large bundle of nerve fibers connecting the left and right hemispheres of the brain — fails to develop normally (agenesis) or develops incompletely (dysgenesis). This grouping, classified under Orphanet code 269573, encompasses numerous distinct genetic syndromes where this brain malformation is a defining or prominent clinical characteristic rather than an incidental finding. The corpus callosum plays a critical role in inter